Your browser doesn't support javascript.
loading
Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer.
Deng, Ou; Dash, Sweta; Nepomuceno, Thales C; Fang, Bin; Yun, Sang Y; Welsh, Eric A; Lawrence, Harshani R; Marchion, Douglas; Koomen, John M; Monteiro, Alvaro N; Rix, Uwe.
Afiliação
  • Deng O; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Dash S; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Nepomuceno TC; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Fang B; Proteomics & Metabolomics Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Yun SY; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA; Chemical Biology Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Welsh EA; Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Lawrence HR; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA; Chemical Biology Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Marchion D; Tissue Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Koomen JM; Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Monteiro AN; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: alvaro.monteiro@moffitt.org.
  • Rix U; Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: uwe.rix@moffitt.org.
J Biol Chem ; 298(11): 102550, 2022 11.
Article em En | MEDLINE | ID: mdl-36183837

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article